泌尿补充品市场 - 按类型、应用、配方、配销通路和预测，2024 年至 2032 年

Urology Supplements Market - By Type, By Application, By Formulation, By Distribution Channel & Forecast, 2024 - 2032

出版日期: 2024年05月02日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在泌尿科疾病盛行率不断上升和预防保健意识不断提高的推动下，泌尿科补充剂市场规模预计在 2024 年至 2032 年期间复合年增长率为 7.4%。随着全球人口老化和生活方式的不断变化，泌尿道感染、肾结石和前列腺疾病等泌尿系统疾病变得更加普遍。

据通报，泌尿道感染在全球普遍存在，每年影响全球 1.5 亿人。营养科学和研究的不断进步已经确定了特定成分，例如锯棕榈、蔓越莓提取物和β-谷甾醇，这些成分因其对泌尿和前列腺健康的有益作用而闻名。

消费者对主动健康管理和泌尿问题预防措施重要性的认识不断提高，也推动了市场的成长。泌尿科补充剂被认为是传统药物治疗的天然和非侵入性替代品，吸引了寻求补充疗法以支持泌尿科健康的个人。电子商务平台的兴起和直接面向消费者的行销策略也将有助于市场扩张。

泌尿外科补充剂产业分为类型、应用、配方、配销通路和地区。

根据应用，由于肾臟相关疾病的盛行率不断增加以及肾臟健康维护意识的不断提高，肾臟健康领域的市场规模预计到 2032 年将产生可观的收入。由蔓越莓萃取物、蒲公英根和维生素 B6 等成分配製而成的泌尿补充剂因其据称具有支持肾功能和泌尿道健康的功效而越来越受欢迎。

片剂配方领域的泌尿补充剂产业将在预测期内成长，这得益于其便利性、易于消费和配方多功能性。片剂形式的泌尿科补充剂为消费者提供了一种便捷的方式，将因其泌尿科益处而闻名的必需营养素和草药提取物融入他们的日常健康习惯中。片剂也因其便携性、更长的保质期和精确的剂量而受到青睐，这吸引了寻求直接和持续补充的消费者。

到2032 年，亚太地区泌尿保健品产业将大幅成长，原因是日本、中国和韩国人口老化加剧，这些地区容易出现与年龄相关的泌尿系统疾病，如良性前列腺增生(BPH) 和泌尿道感染。久坐的生活方式、不健康的饮食和压力等与生活方式相关的因素日益普遍，也将导致泌尿系统疾病的增加，促使人们在该地区寻求预防措施和补充疗法。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Amway
Biotexlife
Himalaya Wellness
Himalayan Organics
Natrol, LLC
Nature's Bounty
Puritan's Pride
Solaray
Theralogix
ZAHLER

简介目录

Product Code: 9332

Urology supplements market size is set to register a 7.4% CAGR during 2024-2032, driven by the increasing prevalence of urological conditions and the rising awareness of preventive healthcare. With the aging global population ages and evolving lifestyles, urological disorders, such as urinary tract infections, kidney stones, and prostate conditions have become more prevalent.

As per reports, urinary tract infections are globally prevalent, affecting 150 million people worldwide every year. Rising advancements in nutritional science and research have identified specific ingredients, such as saw palmetto, cranberry extract, and beta-sitosterol, known for their beneficial effects on urinary and prostate health.

Increasing consumer awareness about the importance of proactive health management and preventive measures against urological issues is also fueling the market growth. Urology supplements are perceived as natural and non-invasive alternatives to traditional pharmaceutical treatments, appealing to individuals seeking complementary therapies to support their urological health. The rise of e-commerce platforms and direct-to-consumer marketing strategies will also contribute to the market expansion.

The urology supplements industry is segmented into type, application, formulation, distribution channel and region.

Based on application, the market size from the kidney health segment is poised to generate substantial revenue by 2032 due to the increasing prevalence of kidney-related disorders and the rising awareness of kidney health maintenance. Urology supplements formulated with ingredients like cranberry extract, dandelion root, and vitamin B6 are gaining popularity for their purported benefits in supporting kidney function and urinary tract health.

Urology supplements industry from the tablets formulation segment is set to grow over the forecast period, led by its convenience, ease of consumption, and formulation versatility. Urology supplements in tablet form offer consumers a convenient way to incorporate essential nutrients and herbal extracts known for their urological benefits into their daily health routines. Tablets are also preferred for their portability, longer shelf life, and precise dosing, which appeals to consumers looking for straightforward and consistent supplementation.

Asia Pacific urology supplements industry will grow significantly through 2032, attributed to the increasing aging population across Japan, China, and South Korea, which is prone to age-related urological conditions, such as benign prostatic hyperplasia (BPH) and urinary tract infections. The growing prevalence of lifestyle-related factors like sedentary lifestyles, unhealthy diets, and stress will also contribute to the rise in urological disorders, prompting individuals to seek preventive measures and complementary therapies in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of urological disorders
  - 3.2.1.2 Advancements in product formulations and delivery systems
  - 3.2.1.3 Increasing emphasis on preventive healthcare
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Potential interactions and side effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Multi-ingredient
5.3 Single ingredient

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Urinary tract infections
6.3 Kidney health
6.4 Prostate health
6.5 Bladder health
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Formulation, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Capsules
7.3 Softgels
7.4 Tablets
7.5 Liquid
7.6 Other formulations

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Brick & mortar
8.3 E-commerce

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa